Journal Home
Search for

Volume 50, Issue 5, Pages A51-A52 (November 2007)


View previous. 8 of 33 View next.

Quiz page November 2007: A Peritoneal Dialysis Patient With HIV Infection and Abdominal Pain

Article Outline

Clinical Presentation

Discussion

What does the abdominal tomography show?

What is your diagnosis?

Final Diagnosis

References

Copyright

Clinical Presentation 

return to Article Outline

A 49-year-old man with human immunodeficiency virus (HIV) and end-stage renal disease was managed with peritoneal dialysis for 5 years. During this time, he experienced 4 mild episodes of peritonitis treated with antibiotics. He now presents with abdominal pain, anorexia, nausea, and vomiting for 15 days. Physical examination shows signs of marked malnutrition, a palpable abdominal mass, and decreased bowel sounds. Abdominal tomography was performed (Fig 1).


View full-size image.

Figure 1. Noncontrasted abdominal tomography.


■What does the abdominal tomography show?

■What is your diagnosis?

Discussion 

return to Article Outline

What does the abdominal tomography show? 

Abdominal tomography in Fig 1 shows extensive calcification of the peritoneum, with the bowel loops incorporated in a cocoon-like mass and loculated ascites.

What is your diagnosis? 

These findings are consistent with the diagnosis of sclerosing encapsulating peritonitis. The patient was transferred to hemodialysis therapy and prescribed tamoxifen, 40 mg, and prednisone, 60 mg/d. Enteral nutrition was started. The patient’s condition initially improved, but he died 2 months later of likely abdominal sepsis. Autopsy was not performed.

Sclerosing encapsulating peritonitis is a rare, but fatal, complication of long-term peritoneal dialysis. It should be suspected in peritoneal dialysis patients who develop a clinical syndrome compatible with bowel obstruction.1 Although the cause is unknown, risk factors include previous episodes of peritonitis, high glucose or lactate dialysate, and such medications as β-blockers and chlorhexidine.2, 3 Steroids and anti-inflammatory and immunosuppressive drugs have been used for treatment, but mortality remains high (60% to 90%).

Final Diagnosis 

return to Article Outline

Massive sclerosing encapsulating peritonitis.

References 

return to Article Outline

1. 1Summers AM, Clancy MJ, Syed F, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int. 2005;685:2381–2388.

2. 2Yamamoto R, Otsuka Y, Nakayama M, et al. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol. 2005;9:148–152. MEDLINE | CrossRef

3. 3Slim R, Tohme C, Yaghi C, Honein K, Sayegh R. Sclerosing encapsulating peritonitis: A diagnostic dilemma. J Am Coll Surg. 2005;200:974–975. Full Text | Full-Text PDF (129 KB) | CrossRef

 Case provided and authored byMaite Rivera, MD, Judith Martins, MD, María Teresa Tenorio, MD, José Luis Teruel, MD, and Joaquín Ortuno, MD, Nephrology Service, Hospital Ramón y Cajal, Madrid, Spain.

 Support: None.

 Financial Disclosure: None.

PII: S0272-6386(07)00953-5

doi:10.1053/j.ajkd.2007.06.020


View previous. 8 of 33 View next.